Get Started

3D Printing Medical Devices Market Projected to Reach $18.61 Billion by 2035

SNS Insider· June 17, 2026

The global 3D printing medical devices market is experiencing rapid growth, driven by the increasing adoption of personalized healthcare solutions and advanced manufacturing technologies. Valued at an estimated $3.71 billion in 2025, the sector is projected to expand to $18.61 billion by 2035, representing a compound annual growth rate of 17.49% during the forecast period. This expansion is fueled by rising demand for patient-specific implants, prosthetics, and surgical guides that improve clinical outcomes while reducing production costs.

The 3D printing medical devices sector is undergoing a transformation led by the integration of selective laser sintering, bioprinting, and AI-powered design software. These technologies enable healthcare providers to implement precision medicine through point-of-care manufacturing and the development of biocompatible raw materials. Key drivers for this growth include a rising incidence of chronic ailments and a shift toward personalized solutions that enhance surgical accuracy and efficiency. The market is also benefiting from increased investment in additive manufacturing and regenerative medicine research.

Major industry players are actively launching new technologies to maintain competitive advantages and expand their global footprint. In February 2025, Stratasys Ltd. introduced a new 3D printing technology with enhanced multi-material capabilities specifically designed for anatomical models and customized surgical guides. Similarly, 3D Systems Corporation announced advancements in workflow automation and imaging technology in August 2024. Meanwhile, Belgium-based Materialise NV expanded its personalized implant services into Asia-Pacific markets, including India and Southeast Asia, in October 2024 to capitalize on emerging healthcare needs in those regions.

Leading companies such as Stratasys, 3D Systems, and Materialise are defining the market through specialized offerings and integrated platforms. Stratasys utilizes PolyJet and FDM technologies for dental applications and surgical planning, while 3D Systems provides a comprehensive platform covering everything from imaging tools to tissue engineering. Other significant contributors to the landscape include medical device giants like Medtronic, Stryker, and Zimmer Biomet, alongside technology firms such as GE Additive, HP Inc., and Carbon Inc., all focusing on increasing the speed and precision of medical device production for individualized patient care.

Read the full story at SNS Insider

Summary generated by RabbitReport AI from public reporting. The full article and original reporting belong to SNS Insider.

More in Medical Devices

The EU Medical Device Shake-Up: What International Companies Should Prepare For

The European Commission has introduced major proposals to amend the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) to address critical implementation challenges and supply chain risks. These reforms aim to streamline regulatory processes and reduce administrative burdens by shifting toward a more proportionate, risk-based system. For the medical device sector, these changes are vital for maintaining market access and ensuring that innovative technologies reach patients without the delays caused by previous regulatory backlogs.

June 21, 2026

CMS and FDA Announce New RAPID Program for Medicare Coverage of Breakthrough Medical Devices

The Centers for Medicare & Medicaid Services (CMS) and the Food and Drug Administration (FDA) have introduced the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway to accelerate patient access to innovative medical technologies. This initiative aims to reduce the historical delay between FDA authorization and Medicare national coverage from over a year to as little as two months for qualifying Breakthrough Devices. By aligning regulatory and reimbursement evidence requirements early in the development process, the program seeks to provide a more predictable commercialization path for manufacturers of Class II and Class III devices.

June 21, 2026

The landscape of artificial intelligence-enabled medical devices in the EU and the US intended for intensive care units

A recent analysis published in Nature examines the current regulatory and market landscape for artificial intelligence-enabled medical devices within intensive care units in the European Union and the United States. The study highlights the growing integration of AI technologies into critical care environments, focusing on how these devices are categorized and approved for clinical use. This overview is significant for the medical device sector as it underscores the technical and regulatory hurdles facing developers of high-stakes diagnostic and monitoring software.

June 21, 2026

MedTech Breakthrough Awards recognize top medical device, medtech innovations

The MedTech Breakthrough Awards have announced their latest recognition of leading innovations within the medical device and healthcare technology sectors. This annual awards program highlights excellence across various categories, including robotics, telehealth, and clinical administration. For the medical device industry, these accolades serve as a benchmark for technological advancement and market leadership among both established firms and emerging startups.

June 21, 2026